Historical record - last NADAC publication: 11/20/2019
Product Information
GEMFIBROZIL 600 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1104 per EA under NDC 75834013118. Its NADAC has been published 121 times since Aug 16, 2017.
The Low Outlier badge above means this manufacturer's average price in the Gemfibrozil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
600 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834013118
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
11/20/2019
Active Ingredients
GEMFIBROZILApproval Type
Generic (ANDA)
FDA Application
ANDA203266On Market Since
2/15/2017
Pharmacological Classes
Price Statistics
The NADAC for GEMFIBROZIL 600 MG TABLET has been published 121 times since Aug 16, 2017, and over the history we have for it it has risen 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1104 per EA |
|---|---|
| All-time high | $0.1158 (Sep 11, 2019) |
| All-time low | $0.0831 (Dec 20, 2017) |
| Median price | $0.0924 |
| Average price | $0.0955 |
| Largest weekly change | +7.7% (Nov 21, 2018) |
| Weeks tracked | 121 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GEMFIBROZIL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1104 per EA (NDC 75834013118), effective Dec 4, 2019.
How has the price of GEMFIBROZIL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has risen 25.0%. It has been tracked across 121 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?
Since Aug 16, 2017, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0831 (Dec 20, 2017) to a high of $0.1158 (Sep 11, 2019), with a median of $0.0924 per EA.
Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 19% below GEMFIBROZIL 600 MG TABLET.
Who manufactures GEMFIBROZIL 600 MG TABLET?
GEMFIBROZIL 600 MG TABLET (NDC 75834013118) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification